Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Delhi: CDSCO raids 45...

    Delhi: CDSCO raids 45 units illegally making Orthopedic medical devices

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-03-14T17:29:03+05:30  |  Updated On 16 Aug 2021 3:16 PM IST

    Central Drugs Standard Control Organization(CDSCO) has conducted raids at 25 factories in Delhi alone. Whereas eight facilities were inspected in Maharashtra and six each in Gujarat and Uttar Pradesh.


    New Delhi: Cracking a whip on companies manufacturing expensive devices without complying quality standards, the central drug regulator along with officers from Central Drugs Standards Control Organisation (CDSCO) has raided 45 medical device plants in the country for unlawfully manufacturing orthopaedic implants. The facilities were involved in manufacturing without a legal license or approval.


    The ongoing activity came to light as a surprise inspection was carried out by 37 inspection teams with 125 officers from the CDSCO.


    During the raid, the drug inspectors observed the "dirty and filthy conditions" for manufacturing the devices, underrated raw materials and lack of quality management and testing facilities.


    Also Read: CDSCO raids 2 firms in Uttarakhand for making drugs without approval

    The facilities are based in Delhi, Uttar Pradesh, Maharashtra and Gujarat. Amongst the four states, Delhi accounted for the maximum number of unapproved facilities. The central regulatory teams conducted raids at 25 factories in Delhi alone. Whereas eight facilities were inspected in Maharashtra and six each in Gujarat and Uttar Pradesh.


    Following the inspection, show cause notices have been issued to the owner of the firms demanding an explanation for violating the regulatory norms.


    Also Read: CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    "We are issuing show cause notices to these facilities and the owner firm asking them to explain the reason for the violation. Once we get their responses, action will be taken under provisions of the Drugs and Cosmetics Act," a senior official told TOI.


    The move assumed is indeed significant as medical devices are rapidly growing segment in India, specifically for high-end implants including cardiac and orthopaedic implants.


    Despite the high prices of these medical devices and overall treatment, medical procedures are increasing at an increased pace.


    Also Read: AGRA: CDSCO issues notice to 72 drug stores for selling prohibited drugs
    Breaking NewsCDSCOCDSCO RaidCentral Drugs Standards Control OrganisationDelhiDrugs and Cosmetics ActGoogle newsGujarathealthIndiamaharashtramedicalMedical Devicesmedical devices standardorthopaedic implantsprostheticraid on medical devicesshow cause noticeUPUttar Pradesh
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok